ÂÜÀòÂÒÂ×

TAHARA HIDETOSHI is the Chief Executive Officer of PURMX Therapeutics since January 2021 and has served as President of the Japanese Association for RNA Interferences since December 2008. With a strong academic background, TAHARA has been a Professor at Hiroshima University since April 2006, contributing to the fields of microRNA, exosomes, and nucleic acid biomedicine. TAHARA obtained a Ph.D. in Cell Biology from Hiroshima University (1989-1994) and a Bachelor of Pharmacy from Tokyo University of Pharmacy and Life Sciences (1985-1989).